Fukoku Mutual Life Insurance’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$271K Sell
516
-34
-6% -$17.9K 0.02% 205
2025
Q1
$349K Hold
550
0.03% 161
2024
Q4
$392K Sell
550
-199
-27% -$142K 0.03% 148
2024
Q3
$787K Hold
749
0.06% 81
2024
Q2
$787K Sell
749
-10
-1% -$10.5K 0.06% 76
2024
Q1
$731K Sell
759
-80
-10% -$77K 0.06% 83
2023
Q4
$737K Buy
839
+303
+57% +$266K 0.06% 94
2023
Q3
$441K Hold
536
0.04% 131
2023
Q2
$385K Hold
536
0.04% 132
2023
Q1
$440K Hold
536
0.04% 120
2022
Q4
$387K Hold
536
0.03% 149
2022
Q3
$369K Buy
536
+100
+23% +$68.8K 0.03% 154
2022
Q2
$258K Sell
436
-124
-22% -$73.4K 0.02% 226
2022
Q1
$391K Sell
560
-50
-8% -$34.9K 0.03% 180
2021
Q4
$385K Sell
610
-1,880
-76% -$1.19M 0.03% 192
2021
Q3
$1.51M Buy
2,490
+2,000
+408% +$1.21M 0.12% 80
2021
Q2
$274K Hold
490
0.02% 225
2021
Q1
$232K Hold
490
0.02% 223
2020
Q4
$237K Hold
490
0.02% 209
2020
Q3
$274K Hold
490
0.03% 177
2020
Q2
$306K Hold
490
0.03% 158
2020
Q1
$239K Hold
490
0.03% 151
2019
Q4
$184K Buy
490
+100
+26% +$37.6K 0.02% 253
2019
Q3
$108K Hold
390
0.01% 269
2019
Q2
$122K Hold
390
0.01% 260
2019
Q1
$160K Hold
390
0.02% 219
2018
Q4
$146K Hold
390
0.02% 223
2018
Q3
$158K Hold
390
0.02% 242
2018
Q2
$135K Hold
390
0.02% 246
2018
Q1
$134K Hold
390
0.02% 251
2017
Q4
$147K Hold
390
0.02% 240
2017
Q3
$174K Buy
390
+30
+8% +$13.4K 0.03% 221
2017
Q2
$177K Hold
360
0.03% 222
2017
Q1
$140K Hold
360
0.02% 226
2016
Q4
$132K Hold
360
0.02% 231
2016
Q3
$145K Sell
360
-40
-10% -$16.1K 0.03% 221
2016
Q2
$140K Hold
400
0.03% 224
2016
Q1
$144K Hold
400
0.03% 230
2015
Q4
$217K Hold
400
0.04% 187
2015
Q3
$186K Sell
400
-100
-20% -$46.5K 0.04% 192
2015
Q2
$255K Hold
500
0.04% 163
2015
Q1
$226K Hold
500
0.04% 170
2014
Q4
$205K Sell
500
-100
-17% -$41K 0.04% 197
2014
Q3
$216K Hold
600
0.04% 201
2014
Q2
$169K Hold
600
0.03% 236
2014
Q1
$180K Hold
600
0.04% 215
2013
Q4
$165K Hold
600
0.03% 237
2013
Q3
$188K Hold
600
0.04% 223
2013
Q2
$135K Buy
+600
New +$135K 0.03% 244